deltatrials
Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06468202

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL (ASPIRIN)

Comparative Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Sponsor: Northwestern University

Updated 8 times since 2024 Last updated: Dec 22, 2025 Started: Oct 18, 2024 Primary completion: Jan 1, 2029 Completion: Feb 1, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Gestational Hypertension and Hypertensive Disorders of Pregnancy, this trial is actively recruiting participants. The trial is conducted by Northwestern University and has accumulated 8 data snapshots since 2024. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshotNot Yet Recruiting~Dec 2024 – ~Mar 2025 · 3 months · monthly snapshotRecruiting~Mar 2025 – ~Jun 2025 · 3 months · monthly snapshotRecruiting~Jun 2025 – ~Jul 2025 · 30 days · monthly snapshot~Jul 2025 – ~Sep 2025 · 2 months · monthly snapshot~Sep 2025 – ~Jan 2026 · 4 months · monthly snapshotRecruiting~Jan 2026 – present · 8 months · monthly snapshotRecruiting

Change History

8 versions recorded
  1. Jan 2026 — Present [monthly]

    Recruiting PHASE4

  2. Sep 2025 — Jan 2026 [monthly]

    Recruiting PHASE4

  3. Jul 2025 — Sep 2025 [monthly]

    Recruiting PHASE4

  4. Jun 2025 — Jul 2025 [monthly]

    Recruiting PHASE4

  5. Mar 2025 — Jun 2025 [monthly]

    Recruiting PHASE4

Show 3 earlier versions
  1. Dec 2024 — Mar 2025 [monthly]

    Recruiting PHASE4

    Status: Not Yet RecruitingRecruiting

  2. Sep 2024 — Dec 2024 [monthly]

    Not Yet Recruiting PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Northwestern University
  • Ohio State University
  • Patient-Centered Outcomes Research Institute
  • Preeclampsia Foundation
Data source: Ohio State University

For direct contact, visit the study record on ClinicalTrials.gov .